A double-blind, randomized, placebo controlled clinical trial on comparing escitalopram and duloxetine add-on for negative symptoms in schizophrenic subjects with neuregulin-1 (NRG1) risk genotype

Project title

比較escitalopram 和duloxetine附加治療帶有第一型神經調節素基因(NRG1)危險基因型的精神分裂症患者的負性症狀的雙盲隨機安慰劑臨床試驗

Internal ID

DOH99-TD-I-111-TM014

Principal Investigator

Start Date

January 1, 2010

End Date

December 12, 2010

Partner Organizations

Ministry of Health and Welfare

Project Web Site